APA (7th ed.) Citation

Mamun-or-Rashid, Roknuzzaman, A. S. M., Sarker, R., Nayem, J., Bhuiyan, M. A., Islam, M. R., & Al Mahmud, Z. (2024). Altered serum interleukin-17A and interleukin-23A levels may be associated with the pathophysiology and development of generalized anxiety disorder. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-66131-9

Chicago Style (17th ed.) Citation

Mamun-or-Rashid, A. S. M. Roknuzzaman, Rapty Sarker, Jannatul Nayem, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam, and Zobaer Al Mahmud. "Altered Serum Interleukin-17A and Interleukin-23A Levels May Be Associated with the Pathophysiology and Development of Generalized Anxiety Disorder." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-66131-9.

MLA (9th ed.) Citation

Mamun-or-Rashid, et al. "Altered Serum Interleukin-17A and Interleukin-23A Levels May Be Associated with the Pathophysiology and Development of Generalized Anxiety Disorder." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-66131-9.